
























































































































































































Total population 215,963 50,146 47,892 47,892
Demographic
Sex (% female) 106,470  (49.3%) 27,881  (55.6%) 26,867 (56.1%) 26,867 (56.1%)
Age in mean years  (SD) 64.6  (11.4) 66.3 (14.4) 66.5 (13.3) 66.4 (14.1)
Prevention‐related activities1
Colonoscopy 666 (0.3%) 131 (0.3%) 102 (0.2%) 130 (0.3%)
Other clinical characteristics1
Inflammatory bowel disease 146 (0.1%) 39 (0.1%) 26 (0.1%) 39 (0.1%)
NSAID use 67,457 (31.2%) 15,631 (31.2%) 15,365 (32.1%) 15,338 (32.0%)
Estrogen use female only 1,463 (1.4%) 341 (1.2%) 320 (1.2%) 339 (1.3%)




















1.5 (1.2) 1.3 (1.2) 1.3 (1.2) 1.3 (1.3)
Number of Different Drugs 4.9 (3.8) 4.2 (3.7) 4.3 (3.6) 4.3 (3.7)
Number of Hospitalizations 0.5 (0.9) 0.3 (0.7) 0.3 (0.7) 0.3 (0.7)





Adjustment HR Lower 95% CI Upper 95% CI
Unadjusted1 0.806 0.733 0.887
Adjusted for age and sex2 0.793 0.699 0.901


















Unadjusted1 0.909 0.786 1.051 0.703 0.620 0.798
Adjusted for age and sex 2 0.958 0.827 1.110 0.785 0.690 0.893











































































Simvastatin 1,492,555 31.44 1,492,555 31.44
Lovastatin 135,679 2.86 1,628,234 34.3
Pravastatin 648,216 13.66 2,276,450 47.96
Fluvastatin 262,931 5.54 2,539,381 53.5
Atorvastatin 1,322,158 27.85 3,861,539 81.35
Rosuvastatin 885,210 18.65 4,746,749 100
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